Antiseizure medications in Alzheimer's disease from preclinical to clinical evidence

F Bosco, L Guarnieri, V Rania, E Palma… - International journal of …, 2023 - mdpi.com
Alzheimer's disease (AD) and epilepsy are common neurological disorders in the elderly. A
bi-directional link between these neurological diseases has been reported, with patients …

The Cognitive and Behavioural Effects of Perampanel in Children with Neurodevelopmental Disorders: A Systematic Review

G Scorrano, S Lattanzi, V Salpietro, C Giannini… - Journal of Clinical …, 2024 - mdpi.com
In children and adolescents with epilepsy, neurodevelopmental comorbidities can impair the
quality of life more than seizures. The aim of this review was to evaluate the cognitive and …

[HTML][HTML] Perampanel for the treatment of epilepsy with genetic aetiology: Real-world evidence from the PERMIT Extension study

N Delanty, R Mohanraj, R Shankar, T Wehner… - Epilepsy Research, 2024 - Elsevier
Genetic factors contribute to the aetiology of epilepsy in> 50% of cases, and information on
the use of antiseizure medications in people with specific aetiologies will help guide …

Effect of age, comedications, and CYP3A4/5 polymorphisms on perampanel exposure in Chinese pediatric patients with epilepsy

H Wang, J Wang, B Lin, H Zhang, Y Sun… - The Journal of …, 2024 - Wiley Online Library
Perampanel (PER) is a new type of antiseizure medication used for partial or generalized
seizures. However, the plasma concentration shows obvious individual variability in …

[HTML][HTML] Perampanel as only add-on epilepsy treatment in elderly: A subgroup analysis of real-world data from retrospective, multicenter, observational study

A Pascarella, S Gasparini, L Manzo, O Marsico… - Journal of the …, 2023 - Elsevier
Introduction Drug management of epilepsy in the elderly presents unique but data on this
population are scarce. This study aimed to assess the effectiveness and tolerability of …

[HTML][HTML] A comprehensive assessment of palmatine as anticonvulsant agent–In vivo and in silico studies

D Nieoczym, M Marszalek-Grabska, R Szalak… - Biomedicine & …, 2024 - Elsevier
Previously, we demonstrated that palmatine (PALM)–an isoquinoline alkaloid from Berberis
sibrica radix, exerted antiseizure activity in the pentylenetetrazole (PTZ)-induced seizure …

Understanding the role of AMPA receptors in autism: insights from circuit and synapse dysfunction

A Jimenez-Gomez, MX Nguyen, JS Gill - Frontiers in Psychiatry, 2024 - frontiersin.org
Autism spectrum disorders represent a diverse etiological spectrum that converge on a
syndrome characterized by discrepant deficits in developmental domains often highlighted …

[HTML][HTML] Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population

G D'Onofrio, R Roberti, A Riva, E Russo, A Verrotti… - …, 2024 - Elsevier
In the landscape of paediatric epilepsy treatment, over 20 anti-seizure medications (ASMs)
have gained approval from Drug Regulatory Agencies, each delineating clear indications …

Harnessing the power of natural alkaloids: the emergent role in epilepsy therapy

S Li, X Lin, L Duan - Frontiers in Pharmacology, 2024 - frontiersin.org
The quest for effective epilepsy treatments has spotlighted natural alkaloids due to their
broad neuropharmacological effects. This review provides a comprehensive analysis of the …

AMPA receptors play an important role in the biological consequences of spinal cord injury: Implications for AMPA receptor modulators for therapeutic benefit

JM Witkin, DP Radin, S Rana, DD Fuller… - Biochemical …, 2024 - Elsevier
Spinal cord injury (SCI) afflicts millions of individuals globally. There are few therapies
available to patients. Ascending and descending excitatory glutamatergic neural circuits in …